These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7735294

  • 1. Role of neuropeptide Y in the regulation of tyrosine hydroxylase messenger ribonucleic acid levels in the male rat arcuate nucleus as evaluated by in situ hybridization.
    Hong M, Li S, Pelletier G.
    J Neuroendocrinol; 1995 Jan; 7(1):25-8. PubMed ID: 7735294
    [Abstract] [Full Text] [Related]

  • 2. Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus.
    Garcia de Yebenes E, Li S, Fournier A, St-Pierre S, Pelletier G.
    Brain Res; 1995 Mar 13; 674(1):112-6. PubMed ID: 7773678
    [Abstract] [Full Text] [Related]

  • 3. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
    Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD.
    Eur J Neurosci; 1993 Dec 01; 5(12):1622-37. PubMed ID: 8124516
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the Y2 receptor subtype in the regulation of prolactin gene expression by neuropeptide Y in the male rat.
    Garcia de Yebenes E, Li S, Fournier A, St-Pierre S, Pelletier G.
    Neurosci Lett; 1995 May 05; 190(2):77-80. PubMed ID: 7644126
    [Abstract] [Full Text] [Related]

  • 5. Role of neuropeptide Y in the regulation of gonadotropin-releasing hormone gene expression in the rat preoptic area.
    Li S, Hong M, Fournier A, St-Pierre S, Pelletier G.
    Brain Res Mol Brain Res; 1994 Oct 05; 26(1-2):69-73. PubMed ID: 7854068
    [Abstract] [Full Text] [Related]

  • 6. Role of neuropeptide Y in the regulation of tyrosine hydroxylase gene expression in rat adrenal glands.
    Hong M, Li S, Fournier A, St-Pierre S, Pelletier G.
    Neuroendocrinology; 1995 Jan 05; 61(1):85-8. PubMed ID: 7731501
    [Abstract] [Full Text] [Related]

  • 7. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
    Gehlert DR, Gackenheimer SL, Schober DA.
    Neurochem Int; 1992 Jul 05; 21(1):45-67. PubMed ID: 1303142
    [Abstract] [Full Text] [Related]

  • 8. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
    Widdowson PS.
    Brain Res; 1993 Dec 17; 631(1):27-38. PubMed ID: 8298993
    [Abstract] [Full Text] [Related]

  • 9. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS.
    Brain Res; 1997 May 30; 758(1-2):17-25. PubMed ID: 9203528
    [Abstract] [Full Text] [Related]

  • 10. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS, Buckingham R, Williams G.
    Brain Res; 1997 Dec 05; 778(1):242-50. PubMed ID: 9462897
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR, Miller RJ, Rhim H, Maclean D, Georgic LM, MacKenzie RG, Grundemar L.
    Br J Pharmacol; 1997 Feb 05; 120(3):481-7. PubMed ID: 9031753
    [Abstract] [Full Text] [Related]

  • 12. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.
    Broberger C, Landry M, Wong H, Walsh JN, Hökfelt T.
    Neuroendocrinology; 1997 Dec 05; 66(6):393-408. PubMed ID: 9430445
    [Abstract] [Full Text] [Related]

  • 13. Antinociceptive effects of neuropeptide Y and related peptides in mice.
    Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Riviere PJ, Junien JL, Dahl SG.
    Brain Res; 1996 Jun 10; 724(1):25-32. PubMed ID: 8816252
    [Abstract] [Full Text] [Related]

  • 14. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6.
    Dickson SL, Luckman SM.
    Endocrinology; 1997 Feb 10; 138(2):771-7. PubMed ID: 9003014
    [Abstract] [Full Text] [Related]

  • 15. Alterations in neuropeptide Y, tyrosine hydroxylase, and Y-receptor subtype distribution following spinal nerve injury to rats.
    Marchand JE, Cepeda MS, Carr DB, Wurm WH, Kream RM.
    Pain; 1999 Feb 10; 79(2-3):187-200. PubMed ID: 10068164
    [Abstract] [Full Text] [Related]

  • 16. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
    Gué M, Junien JL, Reeve JR, Rivier J, Grandt D, Taché Y.
    Br J Pharmacol; 1996 May 10; 118(2):237-42. PubMed ID: 8735621
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y gene expression and receptor autoradiography in hypertensive and normotensive rat brain.
    McLean KJ, Jarrott B, Lawrence AJ.
    Brain Res Mol Brain Res; 1996 Jan 10; 35(1-2):249-59. PubMed ID: 8717361
    [Abstract] [Full Text] [Related]

  • 18. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
    Monnet FP, Fournier A, Debonnel G, de Montigny C.
    J Pharmacol Exp Ther; 1992 Dec 10; 263(3):1212-8. PubMed ID: 1469629
    [Abstract] [Full Text] [Related]

  • 19. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.
    Dumont Y, Cadieux A, Pheng LH, Fournier A, St-Pierre S, Quirion R.
    Brain Res Mol Brain Res; 1994 Oct 10; 26(1-2):320-4. PubMed ID: 7854062
    [Abstract] [Full Text] [Related]

  • 20. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
    Abounader R, Villemure JG, Hamel E.
    Br J Pharmacol; 1995 Oct 10; 116(4):2245-50. PubMed ID: 8564255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.